April 16, 2018

MediMergent and FDA Launch New Stakeholder Initiative against Medication Non-Adherence/Persistence Crisis

ROCKVILLE, Md.–(BUSINESS WIRE)–MediMergent & FDA convened an Advisory Board to oversee a program on improving medication adherence/persistence among patients with chronic diseases.


Leave Comment


Your Name *
Your Email *
Your Website
Comment *